Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.52 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37305 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL8980887 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL6898957 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL2223744 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL879073 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL24530563 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL4804084 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL6559841 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL8579056 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL2845497 | 1.00 | PLA2G1B (0.58) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126051-A | Polymorphic substance of mutant BRAF degradation agent and preparation method thereof | C4医药公司 | 2024-06-04 | — | — | CN | claimed |
| EP-3476826-B1 | ISOCYANATE POLYMERIZATION CATALYST, MANUFACTURING METHOD THEREOF, AND METHOD FOR USING THE CATALYST FOR MANUFACTURING POLYISOCYANATE | WANHUA CHEMICAL GROUP CO LTD (CN) | 2022-09-28 | — | — | EP | claimed |
| CN-114787167-A | Compounds and compositions for the treatment of parasitic diseases | 诺华股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-109563103-B | Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto | 艾尼纳制药公司 | 2022-05-27 | — | — | CN | claimed |
| US-11111332-B2 | Isocyanate polymerization catalyst, preparation method thereof, and method for preparing polyisocyanate by using same | WANHUA CHEMICAL GROUP CO., LTD. | 2021-09-07 | — | — | US | claimed |
| WO-2021078120-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | NOVARTIS AG (CH) | 2021-04-29 | — | — | WO | claimed |
| CN-111699189-A | Modulators of beta-3 adrenergic receptors useful for the treatment or prevention of heart failure and disorders associated therewith | 艾尼纳制药公司 | 2020-09-22 | — | — | CN | claimed |
| CN-108123175-B | Synthesis method of amide compound, amide compound and non-aqueous electrolyte | 微宏动力系统（湖州）有限公司 | 2020-05-22 | — | — | CN | claimed |
| US-20200123300-A1 | Isocyanate Polymerization Catalyst, Preparation Method Thereof, And Method For Preparing Polyisocyanate By Using Same | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2020-04-23 | — | — | US | claimed |
| CN-107021920-B | A kind of isocyanate polymeric catalyst and preparation method thereof, and its method for being used to prepare polyisocyanate | 万华化学集团股份有限公司 | 2019-07-23 | — | — | CN | claimed |
| CN-107021920-A | A kind of isocyanate polymeric catalyst and preparation method thereof, and its method for preparing PIC | 万华化学集团股份有限公司 | 2017-08-08 | — | — | CN | claimed |
| US-20160007593-A1 | Fungicidal Composition | UPL LIMITED (IN) | 2016-01-14 | — | — | US | claimed |
| CN-105101799-A | Fungicidal composition | UPL LTD | 2015-11-25 | — | — | CN | claimed |
| EP-2943067-A1 | FUNGICIDAL COMPOSITION | UPL Limited (IN) | 2015-11-18 | — | — | EP | claimed |
| CN-104203914-A | (hetero) arylcyclopropylamine compounds as LSD1 inhibitors | ORYZON GENOMICS SA | 2014-12-10 | — | — | CN | claimed |
| WO-2014170764-A1 | FUNGICIDAL COMPOSITION | UPL LIMITED (IN) | 2014-10-23 | — | — | WO | claimed |
| CN-101010309-A | Oxopiperidine derivatives, preparation and therapeutic use thereof | SANOFI AVENTIS (FR) | 2007-08-01 | — | — | CN | claimed |
| EP-0644887-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. | SMITHKLINE BEECHAM PLC (GB) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | claimed |
| US-4726835-A | Herbicidal and plant growth regulating imidazoline derivatives | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1988-02-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160007593-A1 | Fungicidal Composition | CYP2C9, CBR3, CYP3A43 | PLA2G1B 4438/4885PLA2G2A 4559/4885OPRM1 2069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.